CONNECT WITH US
AI & Deeptech

AI & Deeptech

GPT-5.5 Bio Bug Bounty

OpenAI News logo

Published on

Add as a preferred source on Google
GPT-5.5 Bio Bug Bounty

As part of our ongoing efforts to strengthen our safeguards for advanced AI capabilities in biology, we’re evolving our GPT‑5.5 Bio Bug Bounty to become an ongoing private program—the OpenAI Bio Bounty Program. The program will remain focused on universal jailbreaks that can defeat our predefined biosafety challenge against OpenAI’s frontier models, starting with GPT‑5.6 and going forward.

We’re also excited to announce that we’re increasing reward amounts. The reward for a universal jailbreak for the OpenAI Bio Bounty Program has been raised from $25,000 to $50,000 for both GPT‑5.6 and GPT‑5.5. Smaller awards may be granted for partial wins at our discretion.

We will continue to honor the scope for the GPT‑5.5 Bio Bounty Program as originally announced, with testing ending on July 27, 2026. After this date, only GPT‑5.6 will be in scope; we will continue to communicate any future changes in scope to our researchers.

Interested applicants should apply through our rolling application process⁠(opens in a new window). Once selected, accepted applicants will be onboarded to the bio bug bounty platform. All past applicants to the GPT‑5.5 Bio Bounty Program will not need to reapply.

Submit a short application here⁠⁠(opens in a new window) (name, affiliation, experience). Accepted applicants must have existing ChatGPT accounts to apply, and will sign a NDA. Apply now and help us make frontier AI safer.

If you’re interested in supporting OpenAI’s work to deliver safe and secure artificial intelligence beyond the Bio Bounty program, you can learn about our Safety Bug Bounty ⁠ (opens in a new window) and Security Bug Bounty ⁠ (opens in a new window) ⁠ programs.


Source link
Related Topics:AI & Deeptech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.